IntelGenX
Our business strategy is to apply our proprietary drug delivery technologies to improve existing drug compounds with proven efficacy and.
Launch date
Employees
Market cap
€26.5m
Enterprise valuation
€41m (Public information from Sep 2024)
Share price
$0.17 IGXT
Montreal Quebec (HQ)
Authorizing premium user...